Laboratory to Perform Assays of Coagulopathy Biomarkers for the National Cancer Institute’s COVID-19 in Cancer Patients Study (NCCAPS)

Search for this grant on NIH site

Program Manager:

Active Dates:

March 1, 2021 -- Feb. 28, 2022

Awarded Amount:

$405,994

Investigator(s):

EDWARD WONG

Funding ICs:

National Cancer Institute (NCI)

Abstract:

Lab will conduct coagulopathy assays for NCI to analyze as part of a correlative science objective in NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study, ClinicalTrials.gov Identifier: NCT04387656 https://clinicaltrials.gov/ct2/show/NCT04387656